FREE CASE EVALUATION

Prominently Featured In:

CNN
Netflix
Newsweek
Business Insider
Time

What Type of Doctor-Patient Relationship Is Expected When a Patient Receives Controlled Substances Prescriptions

The doctor-patient relationship required for legitimate controlled substance prescribing is the same relationship required for any other medical prescription: a relationship established through a personal consultation, an examination appropriate to the presenting complaint, a clinical assessment that produces a diagnosis, and a treatment plan of which the prescription is one component.

The Controlled Substances Act and its implementing regulations require that a prescription for a controlled substance be issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice. Federal courts and the DEA have interpreted this requirement to mean that the prescription must emerge from a genuine doctor-patient relationship in which the practitioner has personally examined the patient, assessed their condition, and exercised independent clinical judgment about whether a controlled substance prescription serves a legitimate therapeutic purpose for that specific patient.

The In-Person Examination Requirement

The traditional requirement for an in-person examination before prescribing controlled substances has been modified in specific circumstances by telemedicine regulations, particularly those enacted or expanded during the COVID-19 public health emergency, but the fundamental requirement that the prescribing be based on a genuine clinical assessment of the patient’s condition remains operative in all circumstances.

A practitioner who issues a controlled substance prescription based solely on a patient’s self-report of symptoms, without any independent clinical assessment of those symptoms, without any examination of the patient, and without any objective basis for the diagnosis that the prescription is supposed to treat, has not conducted the clinical assessment required for legitimate prescribing. This is true whether the prescription is issued in person, over the phone, or through a telemedicine platform.

The Elements of the Required Relationship

The doctor-patient relationship required for legitimate controlled substance prescribing includes several elements that the clinical record should reflect. The practitioner must have established the relationship through an encounter in which the patient’s medical history was reviewed, their present complaint was assessed, and their examination was conducted with sufficient thoroughness to provide a clinical basis for the diagnosis and treatment plan. The practitioner must have reviewed the patient’s existing controlled substance prescription history through the PDMP. The practitioner must have exercised independent clinical judgment in determining that a controlled substance prescription was clinically appropriate rather than simply accepting the patient’s request or a prior practitioner’s prescription as the basis for refilling.

FREE CONSULTATION

Need Help With Your Case?

Don't face criminal charges alone. Our experienced defense attorneys are ready to fight for your rights and freedom.

  • 100% Confidential
  • Response Within 1 Hour
  • No Obligation Consultation

Or call us directly:

(212) 300-5196

Ongoing controlled substance prescribing requires ongoing maintenance of the doctor-patient relationship through regular follow-up visits, reassessment of the treatment’s effectiveness and the patient’s continued need for controlled substances, and monitoring for signs of dependence, misuse, or diversion. The doctor-patient relationship is not established once and maintained indefinitely without reassessment; it requires the continuing exercise of clinical judgment that the initial relationship initiated.

Telemedicine and Its Current Limits

The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 prohibits the prescription of controlled substances based on a telemedicine consultation that did not involve the patient and prescriber in the same physical location at some point, with specific exceptions for DEA-registered telemedicine facilities and certain emergency circumstances. The pandemic-era flexibilities that permitted controlled substance prescribing through audio-visual telemedicine without a prior in-person visit have been subject to ongoing regulatory proceedings that affect their current applicability.

The practitioner who prescribes controlled substances through telemedicine must be aware of the current regulatory status of those prescribing authorizations and must ensure that their telemedicine prescribing complies with both the Ryan Haight Act and any state-specific telemedicine prescribing requirements. Prescribing controlled substances through telemedicine in a manner that does not comply with applicable regulations is prescribing outside the usual course of professional practice regardless of whether the clinical assessment was otherwise thorough.

Todd Spodek
DEFENSE TEAM SPOTLIGHT

Todd Spodek

Lead Attorney & Founder

Featured on Netflix's "Inventing Anna," Todd Spodek brings decades of high-stakes criminal defense experience. His aggressive approach has secured dismissals and acquittals in cases others deemed unwinnable.

NY Bar Admitted Multi-State Licensed Federal Courts
Meet the Full Team

The doctor-patient relationship that supports legitimate controlled substance prescribing is not a formality. It is not a signature on a form or a documented encounter in the electronic health record. It is an actual professional relationship in which a practitioner has taken personal responsibility for understanding a patient’s medical condition and has exercised clinical judgment about that patient’s treatment. The records that reflect that relationship are the records that defend the prescribing. The records that reflect only the transaction are the records that prosecute it.

The Practitioner’s Personal Responsibility

Controlled substance prescriptions must reflect the clinical judgment of the prescribing practitioner, not the judgment of a colleague, a staff member, or a corporate protocol that generates prescriptions without the practitioner’s independent assessment of each patient. A practitioner who signs controlled substance prescriptions generated by staff review of patient files without personally examining the patients has not exercised the clinical judgment the law requires. The prescription carries the practitioner’s DEA registration number. The legal obligation for the prescription is personal.

Share This Article:
Todd Spodek
ABOUT THE AUTHOR

Todd Spodek

Managing Partner

With decades of experience in high-stakes federal criminal defense, Todd Spodek has built a reputation for aggressive, strategic representation. Featured on Netflix's "Inventing Anna," he has successfully defended clients facing federal charges, white-collar allegations, and complex criminal cases in federal courts nationwide.

Bar Admissions: New York State Bar New Jersey State Bar U.S. District Court, SDNY U.S. District Court, EDNY
View Attorney Profile

Community Discussion

Real questions and discussions from readers about this topic.

62
FF former_fed_investigator Former Federal Agent 2w ago

Former investigator perspective on this topic

Retired OIG special agent here. Spent 15 years on the enforcement side. Reading this article and the comments — I want to offer some perspective from the other side of the table.

Most investigations start with data, not complaints. PDMP data, Medicare billing data, pharmacy purchasing records. By the time an agent contacts you, they've usually been looking at your numbers for months. That's why having good documentation matters — the data will flag you, but the documentation either explains the data or doesn't.

70
RD retired_DEA_agent Former Federal Agent 2w ago

Talking. Hands down. Doctors who talked to agents without a lawyer — trying to explain their way out of it — gave us 80% of the evidence we needed. Every single time. Get a lawyer first. Always.

45
FM fed_med_lawyer Attorney 2w ago

Seconding this emphatically. I've represented dozens of healthcare providers. The ones who called me BEFORE talking to agents had dramatically better outcomes than the ones who called AFTER. It's not about having something to hide — it's about having your rights protected from the start.

35
AD anxious_doc_2025 Physician 2w ago

This is incredibly valuable perspective. Can you share — what's the single biggest mistake you saw doctors make when they first learned they were being investigated?

43
AD anxious_doc_2025 DO 1w ago

Going through exactly what this article describes — anyone else?

Just read this article about "What Type of Doctor-Patient Relationship Is Expected When a Patient Receives Controlled Substances Prescriptions" and it hit close to home. I'm a internal medicine doctor and I've been losing sleep over this. My prescribing patterns got flagged by the state PDMP. I haven't been contacted directly by any agency yet but the anxiety is crushing. Anyone been through something similar?

46
HD healthcare_defense_atty Attorney 1w ago

First: do NOT speak to any federal agent without counsel. Period. Not the DEA, not the OIG, not the FBI. You have the right to counsel and exercising that right cannot be held against you.

Second: get a consultation NOW, before anything formal happens. Pre-investigation counsel is dramatically more effective (and less expensive) than post-indictment defense. Many healthcare fraud defense attorneys offer free initial consultations.

Third: do NOT alter any records. Do NOT destroy any documents. Do NOT discuss this with staff beyond what's necessary for patient care. Any of those actions can become separate criminal charges (obstruction, evidence tampering) even if the underlying prescribing was entirely legitimate.

38
BT been_there_doc Physician — Investigated & Cleared 1w ago

Went through a DEA investigation 3 years ago. It was the worst 18 months of my life but I came out clean. Best advice: get a lawyer who specifically handles federal healthcare cases (not a general criminal attorney), follow their instructions to the letter, and keep practicing medicine. The investigation itself is not a conviction and most of your patients still need you.

27
CO compliance_officer_RN Compliance 1w ago

If you haven't already, start documenting everything meticulously going forward. Every prescribing decision should have clear clinical justification in the chart. This protects you regardless of whether an investigation materializes.

38
FM family_member_scared 1w ago

My spouse is a doctor and I’m terrified after reading this

My husband is a primary care physician and we just learned the practice is being looked at by the DEA. We have two young kids. I don't know anything about criminal defense. How do we even start? How much does this cost? Can they take our house?

44
HD healthcare_defense_atty Attorney 1w ago

I understand the fear. Here's what you need to know:

1. Attorney fees: Federal healthcare fraud defense typically costs $20,000-60,000 depending on the stage and complexity. Pre-investigation work is on the lower end.

2. Your home: In most states, homestead exemptions protect your primary residence. Federal forfeiture requires a direct connection between the property and the alleged criminal activity — simply being a doctor who's investigated doesn't put your house at risk.

3. First step: Call a federal healthcare fraud defense attorney this week. Not a general lawyer. Someone who has handled DEA/OIG cases before. Most will do a free phone consultation to assess the situation.

4. Don't panic: Investigation ≠ charges. Charges ≠ conviction. Many investigations are closed without action.

22
DS doc_spouse_survivor 1w ago

I'm the spouse of a physician who went through a 2-year DEA investigation. It was resolved favorably. The emotional toll is real — please consider therapy for both of you. We found a support group for medical professionals under investigation that helped enormously. You're not alone in this.

37
SD solo_doc_2025 Family Medicine 2w ago

How much does a federal healthcare fraud attorney actually cost?

I need to talk to someone but I'm a solo practitioner. I don't have a hospital legal department behind me. What does it actually cost to retain a federal healthcare defense attorney? Just a consultation vs. ongoing representation? Can I even afford this?

42
FM fed_med_lawyer Attorney 2w ago

Typical ranges:

- Initial consultation: Free to $500. Many firms offer free phone consultations.
- Pre-investigation advisory/compliance review: $3,000–$10,000
- Responding to a subpoena: $5,000–$15,000
- Full investigation representation: $25,000–$75,000+
- Trial defense: $100,000–$500,000+

The earlier you engage, the less it costs. A $5,000 consultation that prevents a $50,000 investigation is the best money you'll ever spend. Most attorneys will work out payment plans for solo practitioners.

35
BT been_there_doc Physician — Investigated & Cleared 2w ago

I paid about $35k total for my defense over 18 months. Was it painful? Yes. Would I do it again? In a heartbeat. The alternative — trying to handle it myself or hiring a cheap general attorney — would have cost me my license and my freedom.

35
PO pharmacy_owner_worried PharmD 2w ago

Pharmacist perspective on “What Type of Doctor-Patient Relationship Is Expect”

Running an independent pharmacy and this topic affects us directly. Our state board just issued new guidelines that seem to conflict with DEA expectations. It feels like there's no right answer sometimes. Any other pharmacists dealing with this?

31
HD healthcare_defense_atty Attorney 2w ago

Pharmacists are increasingly being named in federal healthcare fraud cases. Your documentation is your shield. Invest in a compliance program if you don't have one — it's far cheaper than a defense. And know that you DO have the right to refuse to fill prescriptions you believe are not for a legitimate medical purpose. That right is explicitly recognized in federal regulation.

26
FP fellow_pharmacist PharmD 2w ago

You're not alone. The "corresponding responsibility" doctrine puts us in an impossible position. Document EVERYTHING — every conversation with a prescriber about a questionable script, every refusal, every verification call. If you have a compliance program, follow it religiously. If you don't have one, get one yesterday.

35
IP infusion_practice_doc Ketamine Provider 1w ago

Anyone running a ketamine clinic dealing with these issues?

I operate a ketamine-assisted therapy practice and the regulatory landscape feels like it changes monthly. A patient's family filed a complaint about our treatment approach. How are other ketamine providers navigating this?

37
HD healthcare_defense_atty Attorney 1w ago

Ketamine clinics are an emerging enforcement target. The Schedule III classification gives you more flexibility than Schedule II, but the "legitimate medical purpose" standard still applies. The biggest risk areas I see: (1) inadequate patient screening, (2) lack of follow-up care, (3) advertising that makes medical claims beyond what's supported, (4) corporate practice of medicine violations if non-physicians have ownership stakes. Get a compliance review done proactively.

25
AC anesthesia_colleague Psychiatrist 1w ago

Running a ketamine clinic since 2021. The key is airtight protocols and documentation. We have:
- Written treatment protocols for every indication
- Informed consent that specifically addresses off-label use
- Pre-treatment screening including psychological evaluation
- Monitoring during and after infusion
- Follow-up documentation
- Clear exclusion criteria

The DEA has been more interested in compounding pharmacies than individual clinics so far, but that could change. Stay current with ASA and APA guidelines.

26
PA podiatrist_anon DPM 3w ago

Does this apply to podiatrists too?

I'm a veterinarian with a DEA registration. Most of the articles I see focus on physicians and pain management. Are podiatrists really at risk for DEA scrutiny?

28
HD healthcare_defense_atty Attorney 3w ago

Yes. Any DEA registrant who prescribes controlled substances is subject to the same federal standards. Dentists are increasingly scrutinized for opioid prescribing — the CDC's prescribing guidelines have been applied to dental practice. Veterinarians have seen a rise in diversion cases (drugs prescribed for animals being diverted to human use). The DEA does not distinguish by specialty — they look at prescribing patterns and whether they're consistent with legitimate medical practice.

24
NI NP_in_pain_mgmt Nurse Practitioner 1w ago

Does this apply to NPs and PAs too, or just physicians?

I'm a physician assistant with prescriptive authority. Does what this article discusses about "What Type of Doctor-Patient Relationship" apply equally to mid-level providers? I prescribe controlled substances for chronic pain under my collaborating physician's DEA number. If something goes wrong, who is at risk — me, the supervising physician, or both?

28
FM fed_med_lawyer Attorney 1w ago

Both. If you have your own DEA registration, you bear independent responsibility for your prescribing. If you're prescribing under a collaborating physician's DEA number, the supervising physician also has exposure. The DEA does not limit investigations to physicians — NPs, PAs, dentists, podiatrists, and veterinarians have all been targets of federal prescribing investigations.

The same standard applies: prescriptions must be issued for a legitimate medical purpose in the usual course of professional practice. Document your clinical reasoning for every controlled substance prescription.

17
FM fellow_midlevel NP 1w ago

I got my own DEA number specifically so I wouldn't be dragged into my collaborating physician's issues. Worth considering if you haven't already. It also makes your prescribing cleaner from a documentation standpoint.

24
CM clinic_manager_anon Practice Administrator 2w ago

What should clinic staff know about this topic?

I'm a practice manager at a urgent care. After reading about "What Type of Doctor-Patient Relationship" — what should front-line staff (receptionists, medical assistants, billing staff) know? We want to make sure we're not inadvertently creating problems. Should we be training staff differently?

28
CO compliance_officer_RN Compliance 2w ago

Key things for staff:

1. Never alter medical records after the fact for any reason
2. If a federal agent shows up, be polite but say "I need to contact our attorney before providing any information"
3. Don't discuss patient cases with anyone outside the practice
4. Follow your office's prescription verification protocol exactly — no shortcuts
5. Document any patient behavior that seems concerning (doctor shopping, lost prescriptions, etc.)

Annual compliance training for all staff is worth every penny.

Ask the Community

Federal Lawyers By The Numbers

36 Cases Handled This Year and counting
15,536+ Total Clients Served since 2005
95% Case Success Rate dismissals & reduced charges
50+ Years Combined Experience in criminal defense

Data as of February 2026

URGENT

Take Control of Your Situation

Our team is standing by to discuss your legal options

Get Advice From An Experienced Criminal Defense Lawyer

All You Have To Do Is Call (212) 300-5196 To Receive Your Free Case Evaluation.